Detection of Hypoxia Inducible Factors and Angiogenic Growth Factors during Foetal Endochondral and Intramembranous Ossification

Journal of Veterinary Medicine Series C: Anatomia Histologia Embryologia

Volumn 39, Issue 4, 2010, Pages 376-384

  De Spiegelaere, W ^a   Cornillie, P ^a   Casteleyn, C ^a   Burvenich, C ^a   Van den Broeck, W ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; ENDOTHELIAL PAS DOMAIN CONTAINING PROTEIN 1; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SIGNAL PEPTIDE; VASCULOTROPIN A;

ANIMAL; ARTICLE; BONE; BONE DEVELOPMENT; FETUS; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; PRENATAL DEVELOPMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BONE AND BONES; FETUS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OSTEOGENESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SWINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

SUS;

EID: 77955148286     PISSN: 03402096     EISSN: 14390264     Source Type: Journal    
DOI: 10.1111/j.1439-0264.2010.01005.x     Document Type: Article

References (35)

1. Augustin H G, Koh G Y, Thurston G, Alitalo K. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat. Rev. Mol. Cell Biol. 2009, 10:165-177.
2. Buesa R J. Histology without formalin? Ann. Diagn. Pathol. 2008, 12:387-396.
3. Burri P H, Djonov V. Histology without formalin Intussusceptive angiogenesis - the alternative to capillary sprouting. Mol. Aspects Med. 2002, 23:S1-S27.
4. Casteleyn C R, Breugelmans S, Simoens P, Van den Broeck W. Morphological and immunological characteristics of the bovine temporal lymph node and hemal node. Vet. Immunol. Immunopathol. 2008, 126:339-350.
5. Chung U I, Kawaguchi H, Takato T, Nakamura K. Distinct osteogenic mechanisms of bones of distinct origins. J. Orthop. Sci. 2004, 9:410-414.
6. Cox M L, Schray C L, Luster C N, Stewart Z S, Korytko P J, Khan K N M, Paulauskis J D, Dunstan R W. Assessment of fixatives, fixation, and tissue processing on morphology and RNA integrity. Exp. Mol. Pathol. 2006, 80:183-191.
7. Dai J, Rabie A B M. VEGF: an essential mediator of both angiogenesis and endochondral ossification. J. Dent. Res. 2007, 86:937-950.
8. De Spiegelaere W, Erkens T, De Craene J, Burvenich C, Peelman L, Van den Broeck W. Elimination of amplification artifacts in real-time reverse transcription PCR using laser capture microdissected samples. Anal. Biochem. 2008, 382:72-74.
9. De Spiegelaere W, Cornillie P, Van den Broeck W. Localization of erythropoietin in and around growing cartilage. Mol. Cell. Biochem. 2010a, 337:287-291.
10. De Spiegelaere W, Cornillie P, Van den Broeck W. Immunohistochemical detection of the angiopoietins during porcine metanephric kidney development. Acta Histochem. 2010b, 10.1016/j.acthis.2010.05.00, doi
11. Eklund L, Olsen B R. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp. Cell Res. 2006, 312:630-641.
12. Gonzalez L, Anderson I, Deane D, Summers C, Buxton D. Detection of immune system cells in paraffin wax-embedded ovine tissues. J. Comp. Pathol. 2001, 125:41-47.
13. Hanze J, Weissmann N, Grimminger F, Seeger W, Rose F. Cellular and molecular mechanisms of hypoxia-inducible factor driven vascular remodeling. Thromb. Haemost. 2007, 97:774-787.
14. Hicks D J, Johnson L, Mitchell S M, Gough J, Cooley W A, La Ragione R M, Spencer Y I, Wangoo A. Evaluation of zinc salt based fixatives for preserving antigenic determinants for immunohistochemical demonstration of murine immune system cell markers. Biotech. Histochem. 2006, 81:23-30.
15. Hirschberg R M, Plendl J. Pododermal angiogenesis and angioadaptation in the bovine claw. Microsc. Res. Tech. 2005, 66:145-155.
16. Horner A, Bord S, Kelsall A W, Coleman N, Compston J E. Tie2 ligands angiopoietin-1 and angiopoietin-2 are coexpressed with vascular endothelial cell growth factor in growing human bone. Bone 2001, 28:65-71.
17. Hünigen H, Bisplinghoff P, Plendl J, Bahramsoltani M. Vascular dynamics in relation to immunolocalisation of VEGF-A, VEGFR-2 and Ang-2 in the bovine corpus luteum. Acta Histochem. 2008, 110:462-472.
18. Korff T, Kimmina S, Martiny-Baron G, Augustin H G. Blood vessel maturation in a 3-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness. FASEB J. 2001, 15:447-457.
19. Kurz H, Burri P H, Djonov V G. Angiogenesis and vascular remodeling by intussusception: From form to function. News Physiol. Sci. 2003, 18:65-70.
20. Lobov I B, Brooks P C, Lang R. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc. Natl Acad. Sci. USA 2002, 99:11205-11210.
21. Maes C, Carmeliet P, Moermans K, Stockmans I, Smets N, Collen D, Bouillon R, Carmeliet G. Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF(164) and VEGF(188). Mech. Dev. 2002, 111:61-73.
22. Maes C, Stockmans I, Moermans K, Van Looveren R, Smets N, Carmeliet P, Bouillon R, Carmeliet G. Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival. J. Clin. Invest. 2004, 113:188-199.
23. Nguyen V P, Chen S H, Trinh J, Kim H, Coomber B L, Dumont D J. Differential response of lymphatic, venous and arterial endothelial cells to angiopoietin-1 and angiopoietin-2. BMC Cell Biol. 2007, 8:10.
24. Otrock Z K, Makarem J A, Shamseddine A I. Vascular endothelial growth factor family of ligands and receptors: review. Blood Cells Mol. Dis. 2007, 38:258-268.
25. Pfander D, Gelse K. Hypoxia and osteoarthritis: how chondrocytes survive hypoxic environments. Curr. Opin. Rheumatol. 2007, 19:457-462.
26. Ratcliffe P J. HIF-1 and HIF-2: working alone or together in hypoxia? J. Clin. Invest. 2007, 117:862-865.
27. Scharpfenecker M, Fiedler U, Reiss Y, Augustin H G. The Tie-2 ligand Angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J. Cell Sci. 2005, 118:771-780.
28. Schipani E. Hypoxia and HIF-1 alpha in chondrogenesis. Semin. Cell Dev. Biol. 2006, 16:539-546.
29. Schipani E, Ryan H E, Didrickson S, Kobayashi T, Knight M, Johnson R S. Hypoxia in cartilage: HIF-1 alpha is essential for chondrocyte growth arrest and survival. Genes Dev. 2001, 15:2865-2876.
30. Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 2004, 5:343-354.
31. Shomento S H, Wan C, Cao X M, Faugere M C, Bouxsein M L, Clemens T L, Riddle R C. Hypoxia-inducible factors 1 alpha and 2 alpha exert both distinct and overlapping functions in long bone development. J. Cell. Biochem. 2010, 109:196-204.
32. Suzuki T, Miyamoto T, Fujita N, Ninomiya K, Iwasaki R, Toyama Y, Suda T. Osteoblast-specific angiopoietin 1 overexpression increases bone mass. Biochem. Biophys. Res. Commun. 2007, 362:1019-1025.
33. Thompson T J, Owens P D A, Wilson D J. Intramembranous osteogenesis and angiogenesis in the chick embryo. J. Anat. 1989, 166:55-65.
34. Wang Y, Wan C, Deng L F, Liu X M, Cao X M, Gilbert S R, Bouxsein M L, Faugere M C, Guldberg R E, Gerstenfeld L C, Haase V H, Johnson R S, Schipani E, Clemens T L. The hypoxia-inducible factor a pathway couples angiogenesis to osteogenesis during skeletal development. J. Clin. Invest. 2007a, 117:1616-1626.
35. Wang Y, Wan C, Gilbert S R, Clemens T L. Oxygen sensing and osteogenesis. Ann. NY Acad. Sci. 2007b, 1117:1-11.